The disease’s intricacies extend to the classifications of Hormone Receptor (HR)-positive (estrogen and progesterone hormone receptors), Human Epidermal Growth Factor Receptor 2 (HER2)-positive, and Triple-Negative Breast Cancer (TNBC), each presenting unique challenges and insights in the management of breast cancer [7]. Here, ERBB2 is linked to breast carcinoma.